Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera Inc (NQ: NTRA )

123.98 +1.73 (+1.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,020,080
Open 122.40
Bid (Size) 123.98 (1)
Ask (Size) 125.72 (1)
Prev. Close 122.25
Today's Range 121.23 - 124.29
52wk Range 36.90 - 122.48
Shares Outstanding 123,681,432
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber. 
Via Benzinga
Forecasting The Future: 6 Analyst Projections For Natera
Via Benzinga

Performance

YTD
+100.23%
+100.23%
1 Month
+8.34%
+8.34%
3 Month
+14.27%
+14.27%
6 Month
+77.88%
+77.88%
1 Year
+132.56%
+132.56%

More News

Read More
NTRA Stock Earnings: Natera Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Natera Reports Second Quarter 2024 Financial Results
From Natera, Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Via Benzinga
(NTRA) - Analyzing Natera's Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
Via Benzinga
Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Natera, Inc.
Via Business Wire
Natera to Report its Second Quarter 2024 Results on August 8, 2024
From Natera, Inc.
Via Business Wire
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
From Natera, Inc.
Via Business Wire
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
Via Benzinga
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,400 Today
Via Benzinga
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
From Natera, Inc.
Via Business Wire
Trading SMID Biotech Stocks In A Volatile Market
Via Talk Markets
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
From Natera, Inc.
Via Business Wire
Breaking Down Natera: 10 Analysts Share Their Views
Via Benzinga
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
Via MarketBeat
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
From Natera, Inc.
Via Business Wire
Amazon, Natera And A Financial Stock: CNBC's 'Final Trades'
Via Benzinga
(NTRA) - Analyzing Natera's Short Interest
Via Benzinga
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
From Natera, Inc.
Via Business Wire
Cathie Wood-Led Ark Invest Sells Nearly $28M Worth Of Robinhood Shares Amid Crypto API Launch And Lackluster Bitcoin Price Action
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.